Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Striatal dopamine turnover and MIF-I.

R M Kostrzewa, H Fukushima, C T Harston

    Brain Research Bulletin
    |November 1, 1979
    PubMed
    Summary

    L-prolyl-L-leucyl-glycine amide (PLG, MIF-I), an antiparkinsonian agent, was investigated for its effects on dopamine turnover in rat brains. Studies found that MIF-I does not alter dopamine turnover in nigrostriatal neurons.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Measurement of efflux rates from brain to blood.

    Methods in molecular biology (Clifton, N.J.)·1997
    Same author

    Aluminum-sensitive degradation of amyloid beta-protein 1-40 by murine and human intracellular enzymes.

    Neurotoxicology and teratology·1996
    Same author

    Perinatal treatment of rats with opiates affects the development of the blood-brain barrier transport system PTS-1.

    Neurotoxicology and teratology·1996
    Same author

    Differential permeability of the BBB in acute EAE: enhanced transport of TNT-alpha.

    The American journal of physiology·1996
    Same author

    Sequestration of centrally administered insulin by the brain: effects of starvation, aluminum, and TNF-alpha.

    Hormones and behavior·1996
    Same author

    Binding of Tyr-W-MIF-1 (Tyr-Pro-Trp-Gly-NH2) and related peptides to mu 1 and mu 2 opiate receptors.

    Neuroscience letters·1996

    Area of Science:

    • Neuroscience
    • Pharmacology

    Background:

    • Conflicting reports exist regarding the effect of L-prolyl-L-leucyl-glycine amide (PLG, MIF-I) on striatal dopamine turnover.
    • Investigating the precise action of MIF-I is crucial for understanding its antiparkinsonian potential.

    Purpose of the Study:

    • To reinvestigate the actions of MIF-I on striatal dopamine turnover.
    • To clarify the role of MIF-I in regulating dopamine in the nigrostriatal pathway.

    Main Methods:

    • Rats were pretreated with alpha-methyl-p-tyrosine to inhibit dopamine synthesis.
    • Endogenous dopamine decline in the caudate nucleus was measured after MIF-I administration (ICV and IP).
    • Levels of DOPAC and HVA in the rat striatum were analyzed following MIF-I treatment.

    Main Results:

    • MIF-I did not alter the rate of decline of endogenous dopamine in the caudate nucleus.
    • MIF-I administration did not change endogenous DOPAC or HVA levels in the rat striatum.
    • These findings indicate MIF-I does not affect the turnover rate of dopamine in nigrostriatal neurons.

    Conclusions:

    • MIF-I does not appear to modulate dopamine turnover in the nigrostriatal system.
    • It is hypothesized that MIF-I or a related substance may act on postsynaptic receptor sites.
    • Further research is needed to elucidate the exact mechanism of MIF-I's action.

    Related Experiment Videos